Plenary Programme

April 24, 2017

IS ATHEROSCLEROSIS A CHOLESTEROL OR AN IMMUNE DISEASE?

Innate immune response drives atherosclerosis
Mihai G. Netea, Nijmegen, Netherlands

Lowering LDL-C for cardiovascular disease
Chris J. Packard, Glasgow, United Kingdom

Targeting inflammation in atherosclerosis, speaker to be confirmed

Role of non-coding RNA for cholesterol homeostasis and atherogenesis
Kathryn Moore, New York, USA

April 25, 2017

THE BIOLOGY OF TRIGLYCERIDES REVISITED

Balancing the fat: lipid droplets and human disease
Robert Farese, Jr, Boston, USA

Regulation of lipid mobilization and lipoprotein secretion by the intestine
Gary F Lewis, Toronto, Canada

Hepatic lipid and lipoprotein metabolism
Marja-Riitta Taskinen, Helsinki, Finland

Demystifying the management of hypercholesterolaemia
Robert A Hegele, London, Ontario, Canada

April 26, 2017

CARDIOMETABOLIC RISK FACTORS BEYOND LIPIDS

Large-scale epidemiology assessment of the main determinants of cardiovascular disease
Sarah Lewington, Oxford, United Kingdom

Diet and cardiometabolic health
Qi Sun, Boston, USA

Microbiome and cardiometabolic disease
Fredrik Bäckhed, Gothenburg, Sweden

Importance of physical activity in metabolic and cardiovascular health and the influence of obesity and diabetes
Patrick Schrauwen, Maastricht, Netherlands